Gordon S. Jones: Private investment was key for COVID-19 vaccine
Bill to lower the cost of drugs would cripple the development of new medicines.
(Paul Sancya | AP file photo)
In this Jan. 5 photo, a health care worker receives a second Pfizer-BioNTech COVID-19 vaccine shot in Southfield, Mich.
By Gordon S. Jones | Special to The Tribune
| April 27, 2021, 9:00 p.m.
In 1963, Maurice Hilleman, a scientist at Merck, was asleep in his bedroom when his daughter woke him, complaining of a sore throat. After noticing that her jaw was swollen, Hilleman swabbed her throat and rushed to his lab. Four years later, his mumps vaccine was saving lives.